We provide you with 20 years of free, institutional-grade data for HLVX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of HLVX. Explore the full financial landscape of HLVX stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Cocero Nanette | Grant, award...etc | 17,199 | 2025-06-25 | ||
| Gerberding Julie L. | Grant, award...etc | 17,199 | 2025-06-25 | ||
| Dubin Gary | Grant, award...etc | 17,199 | 2025-06-25 | ||
| HILLEMAN JERYL L | Grant, award...etc | 17,199 | 2025-06-25 | ||
| Heron Patrick J | Grant, award...etc | 17,199 | 2025-06-25 | ||
| Sepulveda Jaime | Grant, award...etc | 17,199 | 2025-06-25 | ||
| Kohli Aditya | Grant, award...etc | 17,199 | 2025-06-25 | ||
| Chu Shelley | Grant, award...etc | 17,199 | 2025-06-25 | ||
| Maltbie Shane | Sale | -8,291 | $1.89 | $15,670 | 2025-02-12 |
| HERSHBERG ROBERT | Sale | -26,535 | $1.89 | $50,151 | 2025-02-12 |
| Kohli Aditya | Sale | -18,000 | $15.45 | $278,068 | 2024-05-22 |
| Kohli Aditya | Sale | -6,898 | $14.03 | $96,809 | 2024-05-03 |
| Frazier Life Sciences X, L.P. | Open Market Purchase | 8,850 | $14.5 | 2024-04-08 | |
| Kohli Aditya | Sale | -18,000 | $14.93 | $268,745 | 2024-04-05 |
| McLoughlin Sean | Open Market Purchase | 1,250 | $16.98 | 2024-04-01 | |
| Kohli Aditya | Sale | -18,000 | $17.66 | $317,810 | 2024-03-20 |
| Kohli Aditya | Sale | -18,000 | $18.95 | $341,102 | 2024-03-08 |
| Kohli Aditya | Sale | -18,000 | $14.88 | $267,815 | 2024-02-22 |
| Kohli Aditya | Sale | -6,000 | $15.32 | $91,921 | 2024-02-14 |
| Kohli Aditya | Grant, award...etc | 54,898 | 2024-02-12 | ||
| Kohli Aditya | Sale | -8,866 | $14.93 | $132,383 | 2024-02-12 |
| Maltbie Shane | Grant, award...etc | 47,522 | 2024-02-12 | ||
| Maltbie Shane | Sale | -3,576 | $14.93 | $53,395 | 2024-02-12 |
| HERSHBERG ROBERT | Grant, award...etc | 174,202 | 2024-02-12 | ||
| HERSHBERG ROBERT | Sale | -11,597 | $14.93 | $173,161 | 2024-02-12 |
| Borkowski Astrid | Grant, award...etc | 53,632 | 2024-02-12 | ||
| Borkowski Astrid | Sale | -3,933 | $14.93 | $58,726 | 2024-02-12 |
| Borkowski Astrid | Sale | -10,000 | $15.5 | $155,000 | 2023-12-18 |
| Borkowski Astrid | Sale | -20,000 | $14.2 | $284,000 | 2023-12-05 |
| Borkowski Astrid | Sale | -10,000 | $14 | $140,000 | 2023-11-20 |
| Borkowski Astrid | Sale | -5,000 | $13 | $65,000 | 2023-11-13 |
| Borkowski Astrid | Grant, award...etc | 51,333 | 2023-02-03 | ||
| Kohli Aditya | Grant, award...etc | 85,466 | 2023-02-03 | ||
| HERSHBERG ROBERT | Grant, award...etc | 187,966 | 2023-02-03 | ||
| Maltbie Shane | Grant, award...etc | 43,333 | 2023-02-03 | ||
| Maltbie Shane | Initial | 2023-01-10 | |||
| Frazier Life Sciences X, L.P. | Open Market Purchase | 1,764,706 | $17 | 2022-05-03 | |
| Sepulveda Jaime | Initial | 2022-04-28 | |||
| HERSHBERG ROBERT | Initial | 2022-04-28 | |||
| Silbermann Susan Michele | Initial | 2022-04-28 |
The information provided in this report about HLVX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Hillevax Inc(NASDAQ:HLVX) 
HilleVax, Inc., a clinical-stage biopharmaceutical company, is focused on developing and commercializing novel vaccines. The company is headquartered in Boston, Massachusetts.
Website: https://www.hillevax.com/
Founded: 2020
IPO Price: $17 (Apr 29, 2022)
Sector: TECHNOLOGY
Industry: GENERAL
Share this website to your friends